PubMed

Benefits of information technology-enabled diabetes management.

Bu D, Pan E, Walker J, Adler-Milstein J, Kendrick D, Hook JM, Cusack CM, Bates DW, Middleton B.

Diabetes Care. 2007 May;30(5):1137-42. Epub 2007 Feb 23.PMID: 17322483 [PubMed - indexed for MEDLINE]Related articlesFree article

Information technology for the treatment of diabetes: improving outcomes and controlling costs.

Wyne K.

J Manag Care Pharm. 2008 Mar;14(2 Suppl):S12-7. Review.PMID: 18331115 [PubMed - indexed for MEDLINE]Related articlesFree article

The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.

Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, Lurati FM, Lammert M, Spinas GA.

Curr Med Res Opin. 2004 Aug;20 Suppl 1:S5-26.PMID: 15324513 [PubMed - indexed for MEDLINE]Related articles

Costs and benefits of health information technology.

Shekelle PG, Morton SC, Keeler EB.

Evid Rep Technol Assess (Full Rep). 2006 Apr;(132):1-71. Review.PMID: 17627328 [PubMed - indexed for MEDLINE]Related articlesFree article

Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States.

Minshall ME, Roze S, Palmer AJ, Valentine WJ, Foos V, Ray J, Graham C.

Clin Ther. 2005 Jun;27(6):940-50.PMID: 16117994 [PubMed - indexed for MEDLINE]Related articles

The cost of information technology-enabled diabetes management.

Adler-Milstein J, Bu D, Pan E, Walker J, Kendrick D, Hook JM, Bates DW, Middleton B.

Dis Manag. 2007 Jun;10(3):115-28. Review.PMID: 17590142 [PubMed - indexed for MEDLINE]Related articles

Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting.

Gozzoli V, Palmer AJ, Brandt A, Spinas GA.

Swiss Med Wkly. 2001 Jun 2;131(21-22):303-10.PMID: 11584692 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland.

Brändle M, Azoulay M, Greiner RA.

Int J Clin Pharmacol Ther. 2007 Apr;45(4):203-20.PMID: 17474539 [PubMed - indexed for MEDLINE]Related articles

Impact of changes in HbA1c, lipids and blood pressure on long-term outcomes in type 2 diabetes patients: an analysis using the CORE Diabetes Model.

Palmer AJ, Roze S, Valentine WJ, Minshall ME, Hayes C, Oglesby A, Spinas GA.

Curr Med Res Opin. 2004 Aug;20 Suppl 1:S53-8.PMID: 15324516 [PubMed - indexed for MEDLINE]Related articles

Organizational factors affecting the adoption of diabetes care management processes in physician organizations.

Li R, Simon J, Bodenheimer T, Gillies RR, Casalino L, Schmittdiel J, Shortell SM.

Diabetes Care. 2004 Oct;27(10):2312-6.PMID: 15451893 [PubMed - indexed for MEDLINE]Related articlesFree article

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271. PMID: 18308683 [PubMed - indexed for MEDLINE]Related articlesFree article

The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.

Hoerger TJ, Ahmann AJ.

J Manag Care Pharm. 2008 Feb;14(1 Suppl C):S2-14; quiz 15-6. Review.PMID: 18240890 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of voice- and knowledge-enabled clinical reporting--US example.

Bushko RG, Havlicek PL, Deppert E, Epner S.

Stud Health Technol Inform. 2002;80:265-74.PMID: 12026134 [PubMed - indexed for MEDLINE]Related articles

What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model.

Palmer AJ, Roze S, Valentine WJ, Minshall ME, Lammert M, Oglesby A, Hayes C, Spinas GA.

Curr Med Res Opin. 2004 Aug;20 Suppl 1:S59-66.PMID: 15324517 [PubMed - indexed for MEDLINE]Related articles

Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting.

Roze S, Valentine WJ, Evers T, Palmer AJ.

Curr Med Res Opin. 2006 Jul;22(7):1415-24.PMID: 16834840 [PubMed - indexed for MEDLINE]Related articles

Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group.

Cutler TW, Palmieri J, Khalsa M, Stebbins M.

J Manag Care Pharm. 2007 Sep;13(7):578-88.PMID: 17874864 [PubMed - indexed for MEDLINE]Related articlesFree article

A cost analysis of community screening for diabetes in the central Wisconsin Medicare population (results from the MetaStar pilot project in Wausau).

Lee DS, Remington P, Madagame J, Blustein J.

WMJ. 2000 Jun;99(3):39-43.PMID: 10927980 [PubMed - indexed for MEDLINE]Related articles

Cost of an informatics-based diabetes management program.

Blanchfield BB, Grant RW, Estey GA, Chueh HC, Gazelle GS, Meigs JB.

Int J Technol Assess Health Care. 2006 Spring;22(2):249-54.PMID: 16571201 [PubMed - indexed for MEDLINE]Related articles

Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study.

Karter AJ, Stevens MR, Herman WH, Ettner S, Marrero DG, Safford MM, Engelgau MM, Curb JD, Brown AF; Translating Research Into Action for Diabetes Study Group.

Diabetes Care. 2003 Aug;26(8):2294-9.PMID: 12882851 [PubMed - indexed for MEDLINE]Related articlesFree article

Lifetime costs of complications resulting from type 2 diabetes in the U.S.

Caro JJ, Ward AJ, O'Brien JA.

Diabetes Care. 2002 Mar;25(3):476-81.PMID: 11874933 [PubMed - indexed for MEDLINE]Related articlesFree article